Safety and Immunogenicity of Novel Adenovirus Type 26- and Modified Vaccinia Ankara-Vectored Ebola Vaccines: A Randomized Clinical Trial.
Saved in:
| Title: | Safety and Immunogenicity of Novel Adenovirus Type 26- and Modified Vaccinia Ankara-Vectored Ebola Vaccines: A Randomized Clinical Trial. |
|---|---|
| Authors: | Milligan ID; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, United Kingdom., Gibani MM; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, United Kingdom., Sewell R; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, United Kingdom., Clutterbuck EA; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, United Kingdom., Campbell D; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, United Kingdom., Plested E; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, United Kingdom., Nuthall E; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, United Kingdom., Voysey M; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, United Kingdom2Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, United Kingdom., Silva-Reyes L; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, United Kingdom., McElrath MJ; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington., De Rosa SC; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington., Frahm N; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington., Cohen KW; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington., Shukarev G; Janssen, Pharmaceutical Companies of Johnson & Johnson, Leiden, the Netherlands., Orzabal N; Janssen, Pharmaceutical Companies of Johnson & Johnson, Leiden, the Netherlands., van Duijnhoven W; Janssen, Pharmaceutical Companies of Johnson & Johnson, Leiden, the Netherlands., Truyers C; Janssen, Pharmaceutical Companies of Johnson & Johnson, Leiden, the Netherlands., Bachmayer N; Janssen, Pharmaceutical Companies of Johnson & Johnson, Leiden, the Netherlands., Splinter D; Janssen, Pharmaceutical Companies of Johnson & Johnson, Leiden, the Netherlands., Samy N; Bavarian Nordic, Martinsried, Germany., Pau MG; Janssen, Pharmaceutical Companies of Johnson & Johnson, Leiden, the Netherlands., Schuitemaker H; Janssen, Pharmaceutical Companies of Johnson & Johnson, Leiden, the Netherlands., Luhn K; Janssen, Pharmaceutical Companies of Johnson & Johnson, Leiden, the Netherlands., Callendret B; Janssen, Pharmaceutical Companies of Johnson & Johnson, Leiden, the Netherlands., Van Hoof J; Janssen, Pharmaceutical Companies of Johnson & Johnson, Leiden, the Netherlands., Douoguih M; Janssen, Pharmaceutical Companies of Johnson & Johnson, Leiden, the Netherlands., Ewer K; Jenner Institute, Centre for Clinical Vaccinology and Tropical Medicine, University of Oxford, Oxford, United Kingdom7National Institute for Health Research (NIHR) Oxford Biomedical Research Centre, Oxford, United Kingdom., Angus B; Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom., Pollard AJ; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, United Kingdom7National Institute for Health Research (NIHR) Oxford Biomedical Research Centre, Oxford, United Kingdom., Snape MD; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, United Kingdom7National Institute for Health Research (NIHR) Oxford Biomedical Research Centre, Oxford, United Kingdom. |
| Source: | JAMA [JAMA] 2016 Apr 19; Vol. 315 (15), pp. 1610-23. |
| Publication Type: | Clinical Trial, Phase I; Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: American Medical Association Country of Publication: United States NLM ID: 7501160 Publication Model: Print Cited Medium: Internet ISSN: 1538-3598 (Electronic) Linking ISSN: 00987484 NLM ISO Abbreviation: JAMA Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
